Fatty liver disease as a risk factor for impaired hemostasis in patients with COVID-19
The effect of fatty liver disease (FLD) on hemostasis disorders in COVID-19 was studied. Hemostasis disorders were detected in 30% of COVID-19 deaths. FLD was more common (19%) in COVID-19 deaths with hemostasis disorders than in COVID-19 deaths without hemostasis disorders (12%), p = 0.019. Thus, the study results showed statistical significance of hemostasis pathology in the COVID-19 mortality structure.
Authors
- Olesya V. Tirikova
- Nigina B Elmurodova
- D. V. Sudyarova
Publication Details
- Journal
- Yakut Medical Journal
- Published
- 2025-03-21
- DOI
- https://doi.org/10.25789/ymj.2025.89.25
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00